Researchers at the Max Planck Institute of Biophysics and Heidelberg University have observed largely intact HIV-1 capsids as ...

Human immunodeficiency virus type 1 (HIV-1) targets important cells of our immune system, making infected individuals more ...

The capsule had been in space since June 12 ... produced ritonavir crystals that can be employed in the treatment of HIV. This organic compound inhibits the HIV protease in the human body ...

CCR5 has been through a lot. Since scientists first sequenced it in the 1990s, the human nuclear gene—about 6,000 base pairs, located on chromosome 3—has gone from needle in a genomic haystack, to ...

It looks like a normal capsule, but on reaching the stomach its ... say trials in people could begin within two years. HIV experts said the prospect of a new treatment option was to be welcomed ...

and was bioequivalent to the commercially available capsule. Since the introduction of potent combination antiretroviral therapy involving HIV protease inhibitors, triple-drug therapy consisting ...